Related references
Note: Only part of the references are listed.Engineering Bacteria to Produce Pure Phage-like Particles for Gene Delivery
Matthew Tridgett et al.
ACS SYNTHETIC BIOLOGY (2021)
Enhancing phage therapy through synthetic biology and genome engineering
Bryan R. Lenneman et al.
CURRENT OPINION IN BIOTECHNOLOGY (2021)
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Rebekah M. Dedrick et al.
NATURE MEDICINE (2019)
Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
Nicola Principi et al.
FRONTIERS IN PHARMACOLOGY (2019)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Phage-Based Applications in Synthetic Biology
Sebastien Lemire et al.
ANNUAL REVIEW OF VIROLOGY, VOL 5 (2018)
An Alternative Cure: The Adoption and Survival of Bacteriophage Therapy in the USSR, 1922-1955
Dmitriy Myelnikov
JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES (2018)
Salmonella Phage S16 Tail Fiber Adhesin Features a Rare Polyglycine Rich Domain for Host Recognition
Matthew Dunne et al.
STRUCTURE (2018)
Bacteriophages: Protagonists of a Post-Antibiotic Era
Pilar Domingo-Calap et al.
ANTIBIOTICS-BASEL (2018)
Extending the Host Range of Bacteriophage Particles for DNA Transduction
Ido Yosef et al.
MOLECULAR CELL (2017)
Salmonella Typhi Porins OmpC and OmpF Are Potent Adjuvants for T-Dependent and T-Independent Antigens
Marisol Pérez-Toledo et al.
Frontiers in Immunology (2017)
Safety and efficacy of phage therapy via the intravenous route
Peter Speck et al.
FEMS MICROBIOLOGY LETTERS (2016)
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages
Bruno Martel et al.
NUCLEIC ACIDS RESEARCH (2014)
Long tail fibres of the novel broad-host-range T-even bacteriophage S16 specifically recognize Salmonella OmpC
Roger Marti et al.
MOLECULAR MICROBIOLOGY (2013)
Ceftaroline Fosamil: A Brief Clinical Review
Debbie-Ann T. Shirley et al.
INFECTIOUS DISEASES AND THERAPY (2013)
The host-binding domain of the P2 phage tail spike reveals a trimeric iron-binding structure
Eiki Yamashita et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2011)
Enzymatic assembly of DNA molecules up to several hundred kilobases
Daniel G. Gibson et al.
NATURE METHODS (2009)
Exploring the prokaryotic virosphere
Andre M. Comeau et al.
RESEARCH IN MICROBIOLOGY (2008)
Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the West
Dottore Emiliano Fruciano et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2007)
Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage
Udi Qimron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model
T Matsuda et al.
SURGERY (2005)
Bacteriophage Mu targets the trinucleotide sequence CGG
D Manna et al.
JOURNAL OF BACTERIOLOGY (2005)
Two Salmonella OmpC Kb-restricted epitopes for CD8+-T-cell recognition
A Diaz-Quiñonez et al.
INFECTION AND IMMUNITY (2004)
In vivo recombineering of bacteriophage λ by PCR fragments and single-strand oligonucleotides
AB Oppenheim et al.
VIROLOGY (2004)
The genome sequence of Yersinia pestis bacteriophage φA1122 reveals an intimate history with the coliphage T3 and T7 genomes
E Garcia et al.
JOURNAL OF BACTERIOLOGY (2003)
Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters
HL Bullifent et al.
VACCINE (2000)
Share Paper
